I-SENS, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19,060 KRW | -0.42% |
|
+4.38% | -33.36% |
| Mar. 20 | I-SENS, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | I-SENS, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
| Sales 2024 * | 324B 235M | Sales 2025 * | 392B 285M | Capitalization | 527B 383M |
|---|---|---|---|---|---|
| Net income 2024 * | 29B 21.08M | Net income 2025 * | 44B 31.99M | EV / Sales 2024 * | 1.91 x |
| Net Debt 2024 * | 92B 66.88M | Net Debt 2025 * | 119B 86.51M | EV / Sales 2025 * | 1.65 x |
| P/E ratio 2024 * |
17.7
x | P/E ratio 2025 * |
12
x | Employees | 794 |
| Yield 2024 * |
0.92% | Yield 2025 * |
0.92% | Free-Float | 63.73% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.75% | ||
| 1 week | +4.82% | ||
| Current month | -6.86% | ||
| 1 month | -5.71% | ||
| 3 months | -31.40% | ||
| 6 months | -17.14% | ||
| Current year | -33.08% |
1 week
17 910.00
19 650.00
1 month
17 910.0021 500.00
Current year
17 910.0030 400.00
1 year
14 800.0039 700.00
3 years
12 900.0039 700.00
5 years
7 500.0039 700.00
10 years
7 500.0039 700.00
| Managers | Title | Age | Since |
|---|---|---|---|
Hak-Hyun Nam
FOU | Founder | 64 | 00-05-03 |
Geun-Sig Cha
FOU | Founder | 70 | 00-05-03 |
Sang-Ju Lee
CTO | Chief Tech/Sci/R&D Officer | 58 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Geun-Sig Cha
FOU | Founder | 70 | 00-05-03 |
Hak-Hyun Nam
FOU | Founder | 64 | 00-05-03 |
Jong-Woo Youn
BRD | Director/Board Member | 51 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 19,060 | -0.42% | 50 358 |
| 24-04-24 | 19,140 | -1.75% | 138,879 |
| 24-04-23 | 19,480 | +3.84% | 187,371 |
| 24-04-22 | 18,760 | +2.23% | 152,130 |
| 24-04-19 | 18,350 | -2.55% | 181,408 |
End-of-day quote Korea S.E., April 23, 2024
More quotes
i-SENS, Inc. is a Korea-based company mainly engaged in the manufacture and sale of biosensors. The Companyâs products consist of blood glucose monitoring systems, including blood glucose monitors, blood glucose meters, glucose monitors, blood glucose meter kits and blood sugar meters under the brand names of CareSens, MedTrust, BGStar, Barozen and others; electrolyte analyzers and cartridges; immunosensors, as well as other related accessories, such as connectors, lancets, blood glucose data management software and lancing devices, among others. The Company distributes its products within domestic market and to overseas markets including Japan, Europe, the United States and others.
Calendar
2024-05-13
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
19,140
KRW
Average target price
31,750
KRW
Spread / Average Target
+65.88%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -33.08% | 383M | |
| +72.58% | 12.34B | |
| -18.04% | 7.98B | |
| +3.57% | 5.81B | |
| +6.65% | 5.04B | |
| +20.83% | 4.31B | |
| -20.27% | 4.03B | |
| -41.19% | 2.21B | |
| +0.25% | 1.99B | |
| +4.02% | 1.87B |
- Stock Market
- Equities
- A099190 Stock
